Regulatory & Compliance

Trend Analysis: Medicaid Provider Taxes
Regulatory & Compliance Trend Analysis: Medicaid Provider Taxes

A decades-old financial partnership between states and healthcare providers is now facing an unprecedented federal challenge, threatening to reshape the funding landscape of the nation's largest health insurance program. The Centers for Medicare & Medicaid Services (CMS) has finalized a rule that

Will a New Rule Cut Medicare Advantage Benefits?
Regulatory & Compliance Will a New Rule Cut Medicare Advantage Benefits?

A Looming Showdown: The Battle Over Medicare Advantage Payments For the more than 35 million American seniors enrolled in Medicare Advantage (MA) plans, the promise of comprehensive coverage and extra benefits is a cornerstone of their healthcare. However, a seismic shift may be on the horizon. The

Why Did Integra Recall Wound Devices Linked to 14 Injuries?
Regulatory & Compliance Why Did Integra Recall Wound Devices Linked to 14 Injuries?

Patient Safety in Question Unpacking the Integra Wound Care Recall When a medical device intended to heal instead causes harm, it strikes at the core of patient trust, demanding an immediate and thorough investigation into what went wrong. Medical device company Integra LifeSciences has initiated a

Will a Cigna Settlement Lower Insulin Costs?
Regulatory & Compliance Will a Cigna Settlement Lower Insulin Costs?

The intricate web connecting pharmaceutical manufacturers to patient medicine cabinets is quietly being rewoven as a landmark settlement threatens to expose the secretive financial mechanics driving America's insulin crisis. For years, the rising cost of this life-saving medication has been a

Is Big Insurance Too Powerful for Congress?
Regulatory & Compliance Is Big Insurance Too Powerful for Congress?

With us today is James Maitland, a leading expert on U.S. healthcare policy and the intricate dynamics of the health insurance industry. We're delving into the aftermath of a recent, fiery congressional hearing where lawmakers confronted the CEOs of the nation's largest insurance companies. The

Medtech Group Seeks Tariff Stability and New FDA Rules
Regulatory & Compliance Medtech Group Seeks Tariff Stability and New FDA Rules

The intricate dance between pioneering medical technology and the ever-shifting landscape of government policy has reached a critical juncture, forcing industry leaders to champion a new era of regulatory clarity and trade stability. With global supply chains still fragile and digital health

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later